Schedule 1 Diseases and occupations to which, in addition to pneumoconiosis and byssinosis, this scheme applies
| Description of disease | Nature of occupation |
|---|---|
| 1. Epitheliomatous cancer or ulceration of the skin due to tar, pitch, bitumen, mineral oil (including paraffin), or any compound, product, or residue of any of these substances, including scrotal epithelioma (chimney sweep's cancer). | Any occupation involving: The use or handling of, or exposure to, tar, pitch, bitumen, mineral oil (including paraffin), soot or any compound, product, or residue or any of these substances. |
| 2. Inflammation, ulceration or malignant disease of the skin or subcutaneous tissue or of the bones or anaemia of aplastic type due to X-rays, radium or other radio-active substance. | Exposure to X-rays, radium or other radio-active substance. |
3. (a) Carcinoma of the mucous membrane of the nose or associated air sinuses. (b) Primary carcinoma of a bronchus or of a lung. | Work in a factory where nickel is produced by decomposition of a gaseous nickel compound which necessitates working in or about a building or buildings where that process or any other industrial process ancillary or incidental thereto is carried on. |
4. Primary neoplasm of the epithelial lining of— (a) the urinary bladder (papilloma of the bladder), (b) the renal pelvis, (c) the ureter, or (d) the urethra. | (a) Work in a building in which any of the following substances is produced for commercial purposes— (i) Alpha-naphthylamine or beta-naphthylamine; (ii) diphenyl substituted by at least one nitro or primary amino group or by at least one nitro and primary amino group; (iii) any of the substances mentioned in sub-paragraph (ii) above if further ring substituted by halogeno, methyl or methoxy groups, but not by other groups; (iv) the salts of any of the substances mentioned in subparagraphs (i) to (iii) above; (v) auramine or magenta; (b) the use or handling of any of the substances mentioned in sub-paragraphs (i) to (iv) of paragraph (a), or work in a process in which any such substance is used or handled or is liberated; (c) the maintenance or cleaning of any plant or machinery used in any such process as is mentioned in paragraph (b), or the cleaning of clothing used in any such building as is mentioned in paragraph (a), if such clothing is cleaned within the works of which the building forms a part or in a laundry maintained and used solely in connection with such works. F1(d) exposure to coal tar pitch volatiles produced in aluminium smelting involving the Soderberg process (that is to say the method of producing aluminium by electrolysis in which the anode consists of a paste of petroleum coke and mineral oil which is baked in situ). |
| 5. Primary malignant neoplasm of the mesothelium (diffuse mesothelioma) of the pleura or of the peritonium. | F2Exposure to asbestos, asbestos dust or any admixture of asbestos at a level above that commonly found in the environment at large. |
| 6. Adeno-carcinoma of the nasal cavity or associated air sinuses. | Attendance for work in or about a building where wooden furniture is manufactured. |
| 7. Carcinoma of the nasal cavity or associated air sinuses (nasal carcinoma). | (a) Attendance for work in a building used for the manufacture of footwear or components of footwear made wholly or partly of leather or fibre board; or (b) attendance for work at a place used wholly or mainly for the repair of footwear made wholly or partly of leather or fibre board. |
8. F3Primary carcinoma of the lung where there is accompanying evidence of asbestosis. | (a) The working or handling of asbestos or any admixture of asbestos; or (b) the manufacture or repair of asbestos textiles or other articles containing or composed of asbestos; or (c) the cleaning of any machinery or plant used in any of the foregoing operations and of any chambers, fixtures and appliances for the collection of asbestos dust; or (d) substantial exposure to the dust arising from any of the foregoing operations. |
8A Primary carcinoma of the lung. | Exposure to asbestos for a period of, or periods which amount in aggregate to, five years or more in the course of—
|
8B Unilateral or bilateral diffuse pleural thickening with obliteration of the costophrenic angle. | (a) The working or handling of asbestos or any admixture of asbestos; or (b) the manufacture or repair of asbestos textiles or other articles containing or composed of asbestos; or (c) the cleaning of any machinery or plant used in any of the foregoing operations and of any chambers, fixtures and appliances for the collection of asbestos dust; or (d) substantial exposure to the dust arising from any of the foregoing operations. |
9. F4Primary carcinoma of the lung | (a) F5Work underground in a tin mine; or (b) exposure to bis (chloromethyl) ether produced during the manufacture of chloromethyl methyl ether; or (c) exposure to zinc chromate, calcium chromate or strontium chromate in their pure forms. |
F610. Primary carcinoma of the lung where there is accompanying evidence of silicosis. | Exposure to silica dust in the course of—
|
Annotations
Textual amendments
- F1
Words in Sch. 1 added (24.6.1993) by The Pneumoconiosis, Byssinosis and Miscellaneous Diseases Benefit (Amendment) Scheme 1993 (S.I. 1993/1363), arts. 1(1), 3(2)
- F2
Words in Sch. 1 substituted (9.4.1997) by The Pneumoconiosis, Byssinosis and Miscellaneous Diseases Benefit (Amendment) Scheme 1997 (S.I. 1997/824), arts. 1(1), 3(2)
- F3
Sch. 1 paras. 8-8B substituted for Sch. 1 para. 8 (6.4.2006) by The Pneumoconiosis, Byssinosis and Miscellaneous Diseases Benefit (Amendment) Scheme 2006 (S.I. 2006/638), arts. 1(1), 3
- F4
Words in Sch. 1 substituted (24.6.1993) by The Pneumoconiosis, Byssinosis and Miscellaneous Diseases Benefit (Amendment) Scheme 1993 (S.I. 1993/1363), arts. 1(1), 3(3)
- F5
Words in Sch. 1 inserted (1.4.1987) by The Pneumoconiosis, Byssinosis and Miscellaneous Diseases Benefit (Amendment) Scheme 1987 (S.I. 1987/400), arts. 1, 2(b)
- F6
Sch. 1 entry added (24.6.1993) by The Pneumoconiosis, Byssinosis and Miscellaneous Diseases Benefit (Amendment) Scheme 1993 (S.I. 1993/1363), arts. 1(1), 3(4)